Monitoring of treatment with L-asparaginase in children with acute lymphoblastic leukaemia, with a focus on silent inactivation and its influence on the treatment outcome.
Malgorzata CzogalaIwona RogatkoKatarzyna Pawińska-WąsikowskaWojciech CzogałaWioletta BalMałgorzata CiebieraRadosław ChaberAgnieszka Chodała-GrzywaczGrażyna KarolczykKrystyna SztefkoWalentyna BalwierzSzymon SkoczeńPublished in: Contemporary oncology (Poznan, Poland) (2022)
Monitoring of ASP activity is crucial to recognize silent inactivation and to guarantee treatment effectiveness by switching to other ASP preparations.